Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series

被引：0
|
作者：
Katsuhisa Ohgi
Yusuke Yamamoto
Teiichi Sugiura
Yukiyasu Okamura
Takaaki Ito
Ryo Ashida
Takeshi Aramaki
Katsuhiko Uesaka
机构：
[1] Shizuoka Cancer Center,Division of Hepato
[2] Shizuoka Cancer Center,Biliary
来源：
Annals of Surgical Oncology | 2017年 / 24卷
关键词：
Venous Involvement; Borderline Resectable Pancreatic Cancer (BRPC); Positive Peritoneal Lavage Cytology; Unresectable Group; Venereal Contact;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2752 / 2761
页数：9
相关论文
共 50 条
  • [1] Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series
    Ohgi, Katsuhisa
    Yamamoto, Yusuke
    Sugiura, Teiichi
    Okamura, Yukiyasu
    Ito, Takaaki
    Ashida, Ryo
    Aramaki, Takeshi
    Uesaka, Katsuhiko
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2752 - 2761
  • [2] Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
    Chun, Y.
    Watson, J. C.
    Milestone, B. N.
    Hoffman, J. P.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S26 - S27
  • [3] Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
    Yun Shin Chun
    Barton N. Milestone
    James C. Watson
    Steven J. Cohen
    Barbara Burtness
    Paul F. Engstrom
    Oleh Haluszka
    Jeffrey L. Tokar
    Michael J. Hall
    Crystal S. Denlinger
    Igor Astsaturov
    John P. Hoffman
    Annals of Surgical Oncology, 2010, 17 : 2832 - 2838
  • [4] Defining Venous Involvement in Borderline Resectable Pancreatic Cancer
    Chun, Yun Shin
    Milestone, Barton N.
    Watson, James C.
    Cohen, Steven J.
    Burtness, Barbara
    Engstrom, Paul F.
    Haluszka, Oleh
    Tokar, Jeffrey L.
    Hall, Michael J.
    Denlinger, Crystal S.
    Astsaturov, Igor
    Hoffman, John P.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (11) : 2832 - 2838
  • [5] Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer
    Ravikumar, R.
    Sabin, C.
    Abu Hilal, M.
    Al-Hilli, A.
    Aroori, S.
    Bond-Smith, G.
    Bramhall, S.
    Coldham, C.
    Hammond, J.
    Hutchins, R.
    Imber, C.
    Preziosi, G.
    Saleh, A.
    Silva, M.
    Simpson, J.
    Spoletini, G.
    Stell, D.
    Terrace, J.
    White, S.
    Wigmore, S.
    Fusai, G.
    BRITISH JOURNAL OF SURGERY, 2017, 104 (11) : 1539 - 1548
  • [6] Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer
    Han, Sunjong
    Choi, Seong H.
    Choi, Dong W.
    Heo, Jin S.
    Han, In W.
    Park, Dae-Joon
    Ryu, Youngju
    MINERVA CHIRURGICA, 2020, 75 (01) : 15 - 24
  • [7] Effect of neoadjuvant chemoradiotherapy on prognosis in resectable and borderline resectable pancreatic cancer with venous involvement.
    Nagai, Minako
    Sho, Masayuki
    Akahori, Takahiro
    Nakagawa, Kenji
    Nakamura, Kota
    Takagi, Tadataka
    Tanaka, Toshihiro
    Nishiofuku, Hideyuki
    Kichikawa, Kimihiko
    Ikeda, Naoya
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [8] Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
    Versteijne, E.
    Vogel, J. A.
    Besselink, M. G.
    Busch, O. R. C.
    Wilmink, J. W.
    Daams, J. G.
    van Eijck, C. H. J.
    Koerkamp, B. Groot
    Rasch, C. R. N.
    van Tienhoven, G.
    BRITISH JOURNAL OF SURGERY, 2018, 105 (08) : 946 - 958
  • [9] Efficacy of Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer With Portal Vein or Arterial Involvement
    Nagakawa, Y.
    Takishita, C.
    Hijikata, Y.
    Murakami, Y.
    Yamaue, H.
    Satoi, S.
    Unno, M.
    Isaji, S.
    Endo, I.
    Sho, M.
    Fujii, T.
    Takaori, K.
    Suzuki, S.
    Ohta, T.
    Nagakawa, T.
    Tsuchida, T.
    PANCREAS, 2019, 48 (10) : 1495 - 1495
  • [10] Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials
    van Dam, Jacob L.
    Janssen, Quisette P.
    Besselink, Marc G.
    Homs, Marjolein Y., V
    van Santvoort, Hjalmar C.
    van Tienhoven, Geertjan
    de Wilde, Roeland F.
    Wilmink, Johanna W.
    van Eijck, Casper H. J.
    Koerkamp, Bas Groot
    EUROPEAN JOURNAL OF CANCER, 2022, 160 : 140 - 149
12345